By Joe Messa
Personal injury attorneys report that a jury ruled that Pfizer must pay at least $4 million in damages to a woman who developed breast cancer after taking Prempro. Prempro is a menopause drug manufactured by Wyeth, a unit of Pfizer.
The case was heard in federal court in New Haven, Connecticut. According to the woman’s attorney, jurors called Prempro an “unreasonably dangerous product” that Wyeth handled improperly. They also felt that Wyeth misrepresented the risks and benefits of its drug to patients and doctors
Pfizer will also owe punitive damages to the woman. That amount will be determined by a federal judge at a later time.
Prempro was prescribed to more than 6 million women for the treatment of symptoms such as hot flashes and mood swings. The drug combines the hormones estrogen and progestin in its pills.
In 2002, a study sponsored by the National Institutes of Health was released emphasizing Prempro and other menopause drugs’ links to cancer. The study brought attention to the issue and ultimately resulted in multiple lawsuits against Pfizer on behalf of women who have taken Prempro and were subsequently diagnosed with cancer. Pfizer has lost 11 of the 20 Prempro jury cases since trials began in 2006.
The Philadelphia personal injury attorneys at Messa & Associates are experienced at handling cases involving pharmaceutical and drug product injuries. Our extremely skilled team of personal injury attorneys and medical experts is dedicated to ensuring you receive proper compensation for your personal injuries. If you have been injured by a pharmaceutical drug or negligent medical provider, or have endured any other type of personal injury, contact the personal injury attorneys of Messa & Associates for a free consultation. Call toll free at 1-877-MessaLaw, or submit a free online inquiry.
Joseph L. Messa, Jr. is the founding partner of Messa & Associates, P.C. He is an AV-rated attorney (highest rating available), listed in the Bar Register of Preeminent Lawyers. Read More